News Seattle Genetics leukaemia trial on hold after 4 deaths FDA concerned over potential liver toxicity.
Views & Analysis Exclusive: Brexit likely to cause long-term damage to UK pha... Exclusive survey finds concerns about future of UK pharma industry
News Takeda’s myeloma drug Ninlaro approved in Europe Takeda has gained European Union approval of its multiple myeloma drug Ninlaro for second line use – joining a wave of new treatments for the incurable condition.
News Takeda looks to digitise drug trials with Koneksa Takeda will integrate Koneksa's digital tools and analytics platform to improve their drug development pipeline.
News Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
